| Serial Number | 90664301 |
| Word Mark | GEODE |
| Filing Date | Thursday, April 22, 2021 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Sunday, May 26, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 5, 2022 |
| Goods and Services | Biotechnology and pharmaceutical testing, research, development, and analysis; pharmaceutical, biomedical, and biological therapeutic research and services; pharmaceutical research and development; biological research services; research and development services in the pharmaceutical and biopharmaceutical fields; research and development services in the pharmaceutical and biopharmaceutical fields, namely, in the field of technologies related to proteins and G-protein-coupled receptors (GPCRs); research services in biology fields; pharmaceutical research services in biological drug discovery and development; pharmaceutical research and development services for identifying lead biologics; research and development services in the creation of libraries or collections of biologicals; pharmaceutical research and development in the nature of research, creation, and development of biological drug targets for non-medical scientific screening purposes; pharmaceutical research, analysis, and examination for identification of biologics through automated screening processes; laboratory research, screening, evaluation, and development of biologics; research, studies, and development in the field of pharmaceuticals and biologics; research and development services in biological pharmaceutical development; medical and pharmacological research services; analysis and measurement of pharmaceutical, biomedical, and biological molecules and characteristics; bioanalysis services; biochemical analysis; research and development of medicines; research and development services in the field of antibodies and small proteins; research and development services in the field of antibody and small protein technology; research relating to molecular sciences; research relating to pharmaceuticals; scientific and pharmaceutical research and development, namely, use of in silico, in vitro, and in vivo methods and procedures for biologic, drug, and target production, manipulation, screening, selection, and assaying; provision of information, advisory services, and consultancy relating to the aforesaid services |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 29, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Tectonic Therapeutic, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Watertown, MA 02472 |
| Party Name | Tectonic Therapeutic, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Watertown, MA 02472 |
| Event Date | Event Description |
| Monday, April 26, 2021 | NEW APPLICATION ENTERED |
| Thursday, July 29, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 2, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, December 16, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, November 2, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, November 2, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, January 10, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, January 10, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, January 10, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 1, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, March 1, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, March 1, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, March 1, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, March 1, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 16, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 5, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 5, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 31, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, November 9, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, November 9, 2022 | SOU EXTENSION 1 FILED |
| Wednesday, November 9, 2022 | SOU EXTENSION 1 GRANTED |
| Friday, November 11, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, April 18, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, November 8, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, April 18, 2023 | SOU EXTENSION 2 FILED |
| Tuesday, April 18, 2023 | SOU EXTENSION 2 GRANTED |
| Thursday, April 20, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, November 8, 2023 | SOU EXTENSION 3 FILED |
| Wednesday, November 8, 2023 | SOU EXTENSION 3 GRANTED |
| Friday, November 10, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, April 25, 2024 | USE AMENDMENT FILED |
| Thursday, April 25, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, May 22, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Sunday, May 26, 2024 | STATEMENT OF USE PROCESSING COMPLETE |